Posted: November 19, 2021 / 4:49 PM CST
/ Update: November 19, 2021 / 4:49 PM CST

ST. LOUIS – A cannabis-infused seltzer is on the market at several medical marijuana dispensaries in the St. Louis area. The locally made low dose infused seltzer is called “Society”.

The product is manufactured by Monarch Supply Company. The seltzer is the first of its kind to originate from Missouri. It will be available to medical cannabis patients statewide by early 2022.

Seltzer is made from citrus and tropical ingredients, infused with a tasteless extract in a micro-dose of 5 milligrams of THC.

The drinks are available in three flavors: cherry blossom, blood orange and ginger and lime. The company claims that they are also fast acting and contain 15 calories.

Society comes in a stylish, weathered, resealable 12-ounce tin, and sells for $ 7.

Monarch is a St. Louis-based business and is owned and operated by a local team with 70 years of combined experience in both traditional beer leadership and building craft beer brands.

“Our combined beer and cannabis experience gives our Society beverage portfolio an edge and an advantage,†said Doug Mars, director of operations for Monarch, in a press release.

Prior to Monarch, Mars had a 26-year career with Anheuser-Busch. Most recently, he served as the general manager of a local high-production independent craft brewery and managed the first retail licensed medical dispensary in the early adopted state of Illinois in the Midwest.

Monarch CEO Corey Christanell says the company is appealing to broader trends as well, including as an alternative for millennials and baby boomers who are ditching sugary drinks and drinking less alcohol.

The name “Society” recognizes how sociable an infused drink is, reflecting the brand’s commitment to making cannabis socially acceptable.

Because “the purpose†is a core value of Monarch, the company’s beverage portfolio includes a social impact initiative called Support A Purpose. Support a Purpose is designed to advance the collective efforts of the cannabis community to destigmatize the plant, while allowing customers to fund donations in partnership with their hometown dispensaries for their hometown charities.

DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to provide guidance on certain fourth quarter and year-end results ending December 31, 2021, on the basis of preliminary results:

• The Company expects net revenues for the three-month period ending December 31, 2021 to be between $16.6 million and $17.4 million. This compares to:
  • $14.15 million for the same period in 2020, an increase of between 17% and 23%.
  • $15.2 million sequentially from the third quarter of 2021, an increase of between 9% and 14%.
• The Company expects net revenues for the fiscal year ending December 31, 2021 to be between $61.8 million and $62.6 million, compared to $52.1 million for the same period a year earlier. .

“We expect to report strong year-over-year and sequential revenue results for the fourth quarter of 2021,” said John Arbuthnot, CEO of Delta 9. “Delta 9 strives to differentiate itself from its peers posting strong financial and operational results and continuing to grow its revenue streams from its three main business units.”

Delta 9 will provide investors with a full breakdown of its progress in these areas as part of its year-end and fourth quarter results to be released on March 31, 2022, before markets open, followed by a conference call. , details of which can be found at the end of this press release.

The preliminary estimated financial results and other data for the three-month period and fiscal year ended December 31, 2021, presented above are unaudited and are subject to the completion of the Company’s financial close procedures. These preliminary estimated financial results have been prepared by the Company’s management and are their responsibility. The Company’s independent registered accounting firm, Baker Tilly HMA LLP, is performing year-end audit procedures with respect to the attached preliminary financial results and other data. , and therefore does not express an opinion or any other form of assurance with respect thereto.

The Company currently expects its final operating results and other data to be consistent with the estimates set forth above, but such estimates are preliminary and the Company’s actual operating results and other data may differ materially from these estimates due to the completion of its financial close procedures, final adjustments and other developments that may occur between now and the issuance of these consolidated financial statements for the period ended December 31, 2021.

2021 Year-End Earnings Conference Call

A conference call to discuss the above results is scheduled for March 31, 2022, prior to commercialization. The conference call will be hosted at 9:00 a.m. Eastern Time by John Arbuthnot, Chief Executive Officer, and Jim Lawson, Chief Financial Officer, followed by a question and answer period.

For more information contact:

Investor and media contact:
Ian Chadsey Vice President Corporate Affairs
Mobile: 204-898-7722
E-mail: [email protected]

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The Company sells cannabis products through its wholesale and retail channels and sells its cannabis cultivation pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9 shares trade on the Toronto Stock Exchange under the symbol “DN” and on the OTCQX under the symbol “DLTNF”. For more information, please visit www.delta9.ca.

Disclaimer for forward-looking information

Certain statements in this release are forward-looking statements, which reflect management’s expectations regarding the company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including statements regarding beliefs, plans, expectations or intentions regarding the future. The forward-looking statements contained in this press release include statements relating to Delta 9’s financial results for the three months and year ended December 31, 2021. These statements are subject to risks and uncertainties that may cause results, actual performance or developments differ materially from those contained in the statements, including the Company’s actual financial results which differ from its estimates as well as any risk factors set forth in Delta 9’s Annual Information Form dated March 31, 2021 which was filed on SEDAR. There can be no assurance that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will derive therefrom. Readers are urged to carefully consider these factors when evaluating the forward-looking statements contained in this press release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof, and the Company disclaims any intention or obligation to publicly update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required. by applicable securities. laws.

Written by

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to market to leading companies in the cannabis industry in the United States and abroad.

The Los Angeles County Board of Supervisors agreed on Tuesday, February 15, to move forward with the development and implementation of a “fair” licensing system for commercial cannabis businesses in the areas. unincorporated.

The council’s action means the end is potentially in sight of the county’s years-long ban on marijuana dispensaries and other cannabis-related activities. The county’s ban on marijuana dispensaries in unincorporated areas has been in place since 2010 and was expanded in 2017 to include growing, manufacturing, testing, and distributing the drug for non-personal use. .

California voted to legalize cannabis in 2016 and legal recreational sales began in January 2018.

The council has instructed its Department of Consumer and Corporate Affairs to develop and implement a commercial cannabis licensing program for unincorporated areas, starting with a limited number of licenses while prioritizing to “equity” candidates.

The council-authorized framework allows up to 25 retail, 25 delivery, 10 cultivation, 10 manufacturing, 10 distribution and 10 testing licenses. County officials said limiting the initial number of licenses will ensure permits are distributed fairly in the community.

“A safe, regulated, and equitable cannabis program is needed for unincorporated Los Angeles County and to address the injustices that have caused the disproportionate criminalization of communities of color and the exclusion of economic gains from cannabis legalization” , said Holly, chairwoman of the supervisory board. J. Mitchell, co-sponsor of the motion, said in a statement.

County officials noted that illegal marijuana operations have been a growing problem in many unincorporated areas, creating safety issues for affected neighborhoods and opening up an illegal trade ripe for violence and organized criminal activity.

“Over the past few years, my office and I have worked closely with many community members to combat illegal cannabis businesses in unincorporated areas of the First District,” said Supervisor Hilda Solis, co-author of the motion, in a press release. “And while we were able to quickly and permanently close many illegal dispensaries, our residents remain frustrated with the lack of effective measures to protect their families from the negative impacts of these unlicensed facilities while honoring the intent of California voters who supported the legalization of cannabis.

“To that end, now is the time to begin developing a plan for the legal distribution, retail, manufacture, enforcement and regulation of cannabis in unincorporated Los Angeles County, which is based on equitable access, robust and effective enforcement, and community outreach and education. .”

As part of the council’s action, the DCBA will also provide prospective licensees with referrals and access to education, job training and technical assistance, as well as possible financial assistance.

Until the ministry fully develops the system, all cannabis-related business activities will continue to be illegal in unincorporated areas. It is unclear how long it will take to fully develop the program.

Columbia Care Completes Acquisition of Colorado-based Medicine Man; Strengthens its leadership position in the world’s second largest cannabis market

• Adds four Denver-Metro retail outlets and 35,000 square foot indoor grow facility
• Immediately accelerate Columbia Care’s adjusted EBITDA and operating cash flow
• Solidifies Columbia Care’s Position as the Leading Retailer, Grower and Manufacturer in Colorado

NEW YORK, November 1, 2021– (BUSINESS WIRE) –Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care†or the “Companyâ€), one of largest and most experienced cannabis growers, manufacturers and distributors in the United States, today announced that it has completed the acquisition of Medicine Man, a leading, vertically integrated cannabis company based in the United States. Colorado, which has served the Denver metro area since 2009.

The total initial consideration was $ 42.0 million, including $ 8.4 million in cash and $ 33.6 million in shares, with the possibility of an additional milestone payment based on 2021 performance. The transaction is immediately accretive to Adjusted EBITDA and operating cash flows. The initial consideration of $ 42.0 million represents a multiple of approximately 4.5 times the EBITDA forecast for 2021.

As the second largest cannabis market in the world, Colorado has become a global indicator for adult use programs and continues to show strong organic growth. The acquisition of Medicine Man strengthens our leadership position in the state by combining us with a recognized operator that has consistently outperformed the Colorado market since its inception.

Nicholas Vita, CEO of Columbia Care

We are grateful to the cities of Aurora, Denver and Thornton, and the State of Colorado, for their support, and to the team at Medicine Man who have been great to work with throughout this process. Our vision and values ​​are aligned, and we look forward to expanding our Columbia Care family with the addition of those who have made Medicine Man such a successful business.

The acquisition adds a culture facility and four dispensaries to Columbia Care’s operations in Colorado, including the location of Medicine Man Longmont, which is expected to close in the first quarter of 2022. Columbia Care’s Colorado footprint will now total 26 dispensaries and six growing and manufacturing facilities, including those under the The Green Solution brand.

This marks the next step in the evolution of Medicine Man from an ambitious family business to part of a blue chip operation. Our experience with Columbia Care through this process reinforced the reasons we decided to partner with them.

Sally Vander Veer, CEO of Medicine Man

The team has been amazing, fair and efficient over the past few months. Our goal now is to implement their vision and bring as much value as possible to Operation Columbia Care.

For more information on the transaction, please refer to Columbia Care’s Press release published on June 15, 2021, or visit the presentations section of the investor site.

Advisors

Foley Hoag LLP is legal counsel for Columbia Care. Right Side Advisory Services acts as financial advisor to Medicine Man. Husch Blackwell LLP is acting as legal counsel to Medicine Man.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and suppliers of cannabis products and related services, with licenses in 18 US jurisdictions and the EU. Columbia Care operates 130 facilities, including 99 dispensaries and 31 growing and manufacturing facilities, including those under development. Columbia Care is one of the premier providers of medical cannabis in the United States and now offers cutting-edge products and services to both the medical and adult markets. In 2021, the company launched Cannabist, its new retail brand, creating a nationwide network of dispensaries that operate proprietary technology platforms. The company offers products including flowers, edibles, oils and tablets, and manufactures popular brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Original press release

Get ahead by signing up to 420 Investor, the largest and most comprehensive premium subscription service for cannabis traders and investors since 2013.

Posted by NCV Newswire

New Cannabis Ventures’ NCV Newswire aims to curate high quality content and information on leading cannabis companies to help our readers filter the noise and stay on top of the most important news in the cannabis market. The NCV Newswire is organized by hand by a publisher and is by no means automated. Do you have confidential topical advice? Get in touch.

Receive our Sunday newsletter

---

By ARLEIGH RODGERS – Las Vegas Sunshine

The province has filed a statement to shut down the Indigenous Bloom cannabis store in Portage la Prairie, the provincial regulator’s latest attempt to curb what it claims to be operating an unlicensed retail store.

The Indigenous Bloom store in Portage is a partnership between the Long Plain First Nation and Indigenous Bloom, a British Columbia company.

In May, the provincial regulator terminated the license of another store in which Long Plain First Nation is a partner, Meta Cannabis Supply Co. at 420 Madison St., even though that store was in compliance with all regulations. The status of this store is unclear, although officials at High Tide Inc., a company that acquired cannabis retail chain Meta late last year, have said it is relinquishing. his participation in this store.

Long Plain First Nation Chief Dennis Meeches declined to comment on Friday afternoon after the Manitoba Attorney General’s office issued a press release on the lawsuit seeking an interim and permanent injunction against the landlords of the shop.

The statement noted that the attorney general’s office wishes to “apply a set of rules to everyone.”

In the past, Meeches has claimed the store does not sell unregulated products and has hinted that a legal battle is imminent.

Meanwhile, a store attendant who answered the phone Friday afternoon at the subject native Bloom’s location at 79 Keeshkeemaquah Drive in Portage la Prairie said the store was open.

Some believe this is the first salvo in a battle over Indigenous rights in the cannabis industry, something observers say remained ambiguous in the original federal legislation to legalize recreational cannabis in 2018.

Meeches has said in the past that his band is the government authority “for all matters on our lands”.

The statement states: “The absence of any cannabis store agreement with MBLL (Manitoba Liquor and Lotteries Corp.) and the absence of a retail cannabis store license means that all cannabis sales made in the Indigenous Bloom store are against the law. from Manitoba and Canada.

The attorney general’s office said it was taking action to protect the public interest and was following earlier efforts by provincial cannabis industry regulators to end what it claims to be unlicensed sale of products. unregulated at the Long Plain First Nation Portage store. He said regulators have “extended multiple opportunities to resume participation in the authorized legal framework,” but these actions have not had the desired effect and sales of what he says are commodities. unregulated cannabis continued.

[email protected]

BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. (TSX: DCM) (“DCM” or the “Company”), a leading provider of marketing and corporate communications solutions to businesses across North America, is pleased to provide additional details on its previously announced agreement to provide technology services to a new cannabis customer in the United States.

Under this agreement, DCM will provide technology-based marketing support to a leading multi-state operator (MSO) of cannabis grow and retail sites. DCM’s solution will combine its DCMFlex workflow management platform and content creation software, which allows users to simplify artwork creation with features such as automated templates and the ability to edit cascading all the illustrations concerned, while guaranteeing a locked conformity. The final artwork is then run through DCMFlex for printing or digital publishing.

Marketing cannabis is particularly complex due to stringent state-level legislation that requires cannabis organizations to comply with different production and packaging requirements in each state. As a result, creative asset management is often complicated and error-prone, with multiple facilities and their respective vendors facing inconsistent branding.

With DCMFlex, combined with our advanced content creation and North American production network, our client will have a single source to create, audit, edit and run digital assets. These include packaging, B2C communications, in-store materials and training materials.

Benefits should include better version control, tighter brand oversight, operational transparency, and greater overall efficiency. Simply managing changes on all assets can consume the resources of full-time graphic designers. With DCMFlex, however, the automation and built-in approvals dramatically increase speed to completion and time to market, while reducing the risk of human error that could result in a product recall resulting from improper packaging.

“The fragmentation of the cannabis market presents significant marketing and production challenges that DCM can help address,” said Shelly Anwyll, Senior Vice President, North America, Emerging Markets. “We were really able to dig deep into our toolbox and build a solution that now touches so many aspects of their business. It’s a true marriage of engineering and manufacturing excellence, a complete design-to-execution solution that will evolve and grow alongside their business. And with DCM’s support as a single fulfillment partner, they’ll have fewer vendors to manage. »

ABOUT DATA COMMUNICATIONS MANAGEMENT CORP.

DCM is a leading provider of marketing and workflow solutions that solve complex branding, communications, logistics and regulatory issues for some of North America’s biggest brands. With purpose-built technology like our DCMFlex workflow management platform and ASMBL digital asset management solution, we help clients bring their brands to life and create more meaningful connections with customers. We serve market leaders in key verticals such as financial services, retail, cannabis, energy and the public sector, supporting them with scale to market, speed, efficiency and insight. that boost their competitiveness and improve their performance.

Additional information relating to DATA Communications Management Corp. are available on www.datacm.com, and in disclosure documents filed by DATA Communications Management Corp. on the electronic document analysis and retrieval system (SEDAR) at www.sedar.com.

Forward-looking statements

Certain statements in this press release constitute “forward-looking” statements that involve known and unknown risks, uncertainties and other factors that may cause DCM’s actual results, performance, objectives or achievements, or the results of the industry, are materially different from future results. , performance, objectives or achievements expressed or implied by such forward-looking statements. When used in this press release, words such as “may”, “would”, “could”, “will”, “expect”, “anticipate”, “estimate”, “believe”, “intends”, “plans”, and other similar expressions are intended to identify forward-looking statements. These statements reflect DCM’s current views regarding future events and operating performance, are based on information currently available to DCM, and speak only as of the date of this press release.

These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be construed as guarantees that future performance or results will be achieved. Many factors could cause DCM’s actual results, performance, objectives or achievements to be materially different from any future results, performance, objectives or achievements that may be expressed or implied by such forward-looking statements. Other factors are discussed under the headings “Liquidity and Capital Resources” and “Risks and Uncertainties” in DCM’s MD&A, Annual Information Form and other publicly available disclosure documents, as filed by DCM on SEDAR (www.sedar.com).

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may differ materially from those described in this presentation as anticipated, planned, anticipated, believed, estimated or expected. Except as required by applicable securities laws, DCM does not intend and assumes no obligation to update these forward-looking statements.

The world’s first nationally adopted cannabis software will help standardize, simplify and propel the federally-run medical cannabis industry in Saint-Vincent and the Grenadines

DENVER, August 5, 2021 / PRNewswire / – Akerna Company (Nasdaq: KERN) today announces an exclusive partnership with the Medicinal Cannabis Authority (MCA) in Saint-Vincent-et-les- Grenadines (SVG). As part of this partnership, Akerna will provide MCA with a customer relationship management (CRM) tool specially developed to strengthen the medicinal cannabis industry in the Caribbean countries while meeting regulatory requirements and creating a user-friendly experience. This program will serve as a national model that can be replicated to meet all global cannabis regulations.

This program will serve as a national model that can be replicated to meet all global cannabis regulations.

The medicinal cannabis industry at SVG exists within parameters and mandates defined by local laws and international traceability treaties that govern controlled substances. These parameters require precise monitoring of medicinal cannabis which, combined with the requirements for authorization of personal possession, require significant documentation that must be completed for each patient.

The CRM implemented by Ample Organics, an Akerna company, is expected to dramatically simplify this documentation process and enable rapid assessment of the patient access platform, improving data retrieval, data availability for the patient. MCA and an overall physician, pharmacist and patient friendly experience.

“After seeing the success of Akerna’s Ample Organics product in Canada, the Medicinal Cannabis Authority of SVG was interested in partnering to create software to meet their specific regulatory and compliance needs, â€said Jessica billingsley, CEO of Akerna. “This is the first-ever implementation of a nationwide CRM system within the cannabis industry and will serve as a model for other countries or regions looking to implement a standardized system to nationwide. ”

“The new workflows will provide a better organization of information and increase the efficiency of monitoring and analysis processes, reducing the need for time, paper and human resources, in order to maximize productivity,” said said dr. Jerrol thompson, CEO of the Medicinal Cannabis Authority. “The MCA wanted to express its sincere thanks to Ample Organics and the rest of the Akerna family for guiding SVG through the various challenges of starting a cannabis market, allowing us to reach this successful stage today. ”

Saint-Vincent and the Grenadines strives to be the best regulated medicinal cannabis industry in the world Caribbean, with high quality products recognized for local use and for export, which meet the highest international and industrial standards. The vision of the cannabis industry in SVG integrates the entire value chain of this drug, including Good Agricultural and Collection Practices (GACP), Good Manufacturing Processes (GMP), export and l local patient access. The industry was designed to maximize its impact on the Vincentian workforce and economy and is expected to be an important driver of technological innovation and contribute to the growth of the agricultural, industrial, medical and tourism sectors.

About Ample Organics:

Founded in 2014 and acquired by Akerna in 2020, Ample Organics is adopted by more Canadian licensees than any other cannabis software solution. A complete ecosystem for cannabis companies, the technology platform facilitates compliance by tracking individual plants from seed to consumer and reporting every detail of the growth, production and sales processes. Our team of cannabis industry and tech experts designed the platform to facilitate compliance and transparency while improving overall business efficiency and operational intelligence. The software continues to be the most reliable solution for cannabis growers, manufacturers, distributors, physicians, clinics, laboratories, retailers and educators. Visit AmpleOrganics.com.

About Akerna:

Akerna (Nasdaq: KERN) is a service-oriented enterprise software company compliant with the cannabis, hemp, and CBD industries. Situated at Denver, Colorado, the company’s mission is to create the world’s most transparent and responsible supply chain by creating a cannabis technology ecosystem connecting data points across the global supply chain for cannabis, seed for sale to oneself. First launched in 2010, Akerna has followed more than $ 20 billion in cannabis sales to date and was the first cannabis software company listed on the Nasdaq.

Using connected data and information to power the cannabis industry, Akerna empowers businesses, governments, patients and consumers to make smart decisions. The company’s core technology, the MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors and growers. Akerna also offers a full suite of professional consulting and data analysis services for business as well as solo science, MJ Freeway, Leaf Data Systems, Trellis, Ample Organics and Viridian Sciences.

About the Medicinal Cannabis Authority:

The Medicinal Cannabis Authority was created under the Medicinal Cannabis Industry Act, 2018. It is a legal person with the mandate to regulate the cultivation, supply, possession, production and use of cannabis for medical purposes. This mandate is part of the government of Saint-Vincent and the Grenadines vision to establish a well-regulated and export-oriented medicinal cannabis industry. Visit MCA.VC.

Saint-Vincent and the Grenadines has established a well-regulated, high-quality, export-oriented medicinal cannabis industry. He strives to be a leader and an example of how a small nation with big dreams, ideas and well-designed plans can successfully establish a world-class medicinal cannabis industry. A critical part of this is the local availability of medicinal cannabis for local patients and visitors with appropriate eligible diseases and to do so in a very efficient and professional manner.

Forward-looking statements

Certain statements made in this press release and any accompanying statements by management are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, words “estimates”, “plans”, “expects”, “anticipates”, “plans”, “plans”, “intention”, “believes”, “research”, “may”, “may”, “should” , “Should”, “the future”, “propose” and variations of such similar words or phrases (or negative versions of such words or phrases) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the CRM implemented by Ample which are expected to significantly simplify the documentation process and enable rapid assessment of the Patient Access Platform, improving data retrieval. , availability of data for the MCA and overall user-friendly experience and any other statements expressing the views of Akerna management on future business results or strategy. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of ‘Akerna, which could lead to actual results or results. (including, without limitation, the results of Akerna’s contracts, strategic initiatives and business plans as described herein) differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect results or actual results, include (i) Akerna’s ability to recognize the expected benefits of being a public company, (ii) competition, (iii) ability of Akerna to grow and manage its growth profitably, (iv) Akerna’s ability to maintain customer and supplier relationships and retain its management and key employees, (v) costs associated with to be a public company, (vi) changes in applicable laws or regulations, (vii) Akerna’s ability to identify, complete and integrate acquisitions, including Viridian, and achieve expected synergies and operational efficiencies in in connection with the acquired businesses, (viii) and other risks and uncertainties disclosed from time to time in the documents filed by Akerna with the United States Securities and Exchange Commission, including those mentioned in section n “Risk factorsâ€. Actual results, performance or achievements may differ materially, and potentially negatively, from any projections and forward-looking statements and the assumptions on which they differ from forward-looking statements. There can be no assurance that the data contained in this document reflects to any degree future performance. You are cautioned not to place undue reliance on forward-looking statements as predictors of future performance, as projected financial and other information is based on estimates and assumptions which are inherently subject to various risks, uncertainties and other important factors, including many are beyond Akerna’s control. All information contained herein is valid only as of the date hereof, in the case of information about Akerna, or as of the date of such information, in the case of information from persons other than Akerna. Akerna assumes no obligation to update or revise the information contained in this document. Forecasts and estimates for Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance that such forecasts and estimates will prove to be correct in whole or in part.

View original content to download multimedia: https://www.prnewswire.com/news-releases/akerna-secures-worlds-first-national-government-cannabis-contract-with-st-vincent-and-the-grenadines -301349313 .html

SOURCE Akerna

Shoppers swinging through a popular antique and farmers’ market this weekend in Berks County may find themselves in the midst of a cultural revolution.

The Pennsylvania Cannabis Fall Marketplace is back for a third year at Renninger’s Antique and Farmers’ Market, 740 Noble St. just outside of Kutztown in Maxatawny Township. It’s free, open to the public and family, and pet-friendly, the organizers say on the event’s Facebook page. Hours are 10 a.m. to 5 p.m. Saturday and Sunday.

The event comes the same week that two lawmakers in western Pennsylvania unveiled new legislation to decriminalize, regulate and tax adult recreational marijuana statewide. The proposal was not immediately listed on the state legislature’s website, but it will be labeled House Bill 2050, said state officials Jake Wheatley and Dan Frankel, both D- Allegheny.

It is unclear whether House Speaker Bryan Cutler, R-Lancaster, will propose a vote in the 2021-2022 legislative session. Cutler said two years ago that he opposed the legalization of recreational marijuana for adult use, “in the midst of an opioid epidemic.” His point of view had not changed a year ago, his opposition shared by Senate Majority Leader Jake Corman of R-Center County, pennlive.com reported. Democratic Governor Tom Wolf is a strong supporter of legalization.

The Democrats’ bill would allow anyone aged 21 and over to purchase and consume marijuana recreationally in Pennsylvania.

The proposal would also provide for direct participation in the cannabis industry by individuals in communities that have been disproportionately affected by the criminalization of marijuana, and by small, diverse and disadvantaged businesses, thus laying the groundwork for improvement. of social and economic equity for the individuals and communities who have been and continue to be affected by the criminalization of marijuana, lawmakers said in a press release Tuesday.

“I am once again championing efforts to legalize recreational marijuana for adult use in Pennsylvania,†said Wheatley, who first introduced similar legislation in 2017, to pass the initiative.

“Not only would it create much-needed jobs and income, but it contains important social justice provisions that would eliminate the aggressive enforcement of simple possession of marijuana laws in marginalized communities.”

HB 2050 would also establish several grant programs that would benefit small businesses, minorities, and women in Pennsylvania. These programs would be funded by revenue from the sales tax on marijuana. Ultimately, this legislation would have lasting impacts on economic and social justice in the Commonwealth.

“The failures of past cannabis policies have resulted in the worst possible worlds: insufficient public health protection, aggressive enforcement that disproportionately harms communities of color and zero income for this Commonwealth,†Frankel said. , who is the Speaker of the House Minority. Health Committee. “With this legislation, Pennsylvania can begin to repair historic damage and reap the benefits of an evidence-based approach to regulating the cultivation, trade, and use of cannabis for adults over the age of 21.”

If passed, Pennsylvania will join 16 other states, including neighbors New York and New Jersey, in legalizing recreational marijuana for adult use, lawmakers have said.

This weekend’s Cannabis Festival features over 250 vendors, live music and more. Paid roundtables are scheduled for adult cannabis use on Saturday and medical use on Sunday, including a review of the Pennsylvania medical marijuana program established under legislation enacted by Wolf in April 2016 .

Founded in Scranton in 2015, the Pennsylvania Cannabis Festival first moved to Kutztown for a fall 2019 event, and a fall event also took place in 2020. A spring version returned to Renninger last April. following a cancellation in 2020 due to the coronavirus.

Our journalism needs your support. Please register today at lehighvalleylive.com.

Kurt Bresswein can be reached at [email protected].